What's happening now

During this in-person event, we are bringing together academic researchers from the Oncode Institute and industrial experts in the field of (immune-)oncology. Several experts in cancer drug discovery will present about topics such as: best practices for (early) target identification and validation, hit finding, and further downstream hit-to-lead activities.  

Join us at Discovery US and network with us and over 350 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimisation.

The 11th Drug Discovery Strategic Summit in Amsterdam on November 9-10 is the place to meet our experts and to find out more about our Assay Development, ultra-High Throughput Screening & Mass Spectrometry possibilities.

Meet our experts in Leipzig on October 24-26, where
Pivot Park Screening Centre (PPSC) will be attending BioEurope Fall 2022.

Meet our experts in München on October 5-6 at the 17th Drug Discovery Innovation Programme.

Pivot Park Screening Centre (PPSC) will be attending Drug Discovery 2022; driving the next life science revolution. Meet our experts in London on October 4-5.

The SLAS 2022 AI-Powered Drug Discovery Symposium brings us to the United Stated! Will we see you there?

We’re excited to be in Nice, France for the XXVII EFMC International Symposium on Medicinal Chemistry.